Tara Lech on Bridging a Critical Gap: A New Toolkit for Anticoagulation from Menstruation to Menopause
Tara Lech, Director of Anticoagulation Services at Beth Israel Lahey Health, quoted Divyaswathi Citla Sridhar’s post on LinkedIn:
“Check out this fantastic resource to help you better understand and manage anticoagulation in patients that menstruate
It was an honor to collaborate with these outstanding SHEros in Antithrombotic Stewardship: Divyaswathi Citla Sridhar, Shruti Karanth, Andrea Van Beek, Bethany Samuelson Bannow
Please check out the toolkit and share it with your colleagues!”
Quoting Divyaswathi Citla Sridhar’s post:
“How is anticoagulation different for individuals that menstruate ? It’s not just about periods.
Menarche, pregnancy, contraception, menopause — each uniquely affects thrombosis and bleeding risk. Yet we don’t learn or teach about this enough!
That’s why stewardship matters.
Our new JTH paper — “Anticoagulation Stewardship from Menstruation to Menopause: A Toolkit for Clinical Management” aims to bridge those gaps with practical, evidence-based guidance for clinicians.
So proud to work with this powerhouse group who care deeply about getting it right”
Title: Anticoagulation Stewardship from Menstruation to Menopause: A Toolkit for Clinical Management
Authors: Divyaswathi Citla-Sridhar, Shruti Karanth, Andrea Van Beek, Tara Lech, Bethany Samuelson Bannow
Read full paper here.
Discover the latest in Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring